In the context of glioblastoma, TGF-β2 is particularly significant due to its high expression levels in approximately 90% of glioblastoma cellss known for promoting immune suppression within the tumor microenvironment, which can contribute to tumor growth and resistance to treatments [46–48]. This evidence concerns the gene TGFB2 and glioblastoma.